Literature DB >> 21558477

Thioredoxin, adiponectin and clinical course of acute fulminant myocarditis.

Jin-Oh Choi1, Soo-Hyeon Yun, Kiick Sung, Young Tak Lee, Joong-Il Park, Eun-Seon Ju, Sang-Chol Lee, Seung Woo Park, Duk-Kyung Kim, Jae K Oh, Eun-Seok Jeon.   

Abstract

BACKGROUND: In an animal model of viral myocarditis, plasma levels of thioredoxin and adiponectin have been reported to be associated with the severity of inflammation and recovery of ventricular dysfunction, respectively. However, there have been few reports about the clinical significance of these cytokine levels in human myocarditis.
OBJECTIVES: To examine the hypothesis that cytokine levels correlate with clinical courses of patients with acute fulminant myocarditis (FM).
METHODS: A total of 33 consecutive patients with biopsy-proven acute myocarditis were evaluated. Twenty patients were ascribed to an FM group and the other 13 patients were grouped as a non-fulminant group (NFM). Plasma cytokine levels at the time of admission and after 2 weeks were evaluated and correlated with the duration of mechanical circulatory support application.
RESULTS: Plasma thioredoxin level at admission was raised in the FM group (3.08±2.15 ng/ml) compared with the NFM group (1.63±0.45 ng/ml, p=0.011) and reduced after an initial unstable period. However there was no significant difference in plasma adiponectin level between the two groups. In a multivariable regression model, increased plasma thioredoxin level (OR=5.79, 95% CI 1.67 to 20.1, p=0.006) and reduced plasma adiponectin level (OR=0.16, 95% CI 0.055 to 0.49, p=0.001) were associated with longer duration of mechanical circulatory support application in the patients with FM, which in turn was significantly related to death or cardiac transplantation.
CONCLUSION: In patients with acute myocarditis, the plasma thioredoxin level was increased in the more severe form, and a reduced level of adiponectin was closely correlated with worse short-term outcome in patients with FM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558477     DOI: 10.1136/hrt.2010.219568

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  4 in total

Review 1.  Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.

Authors:  Bernhard Maisch; Volker Ruppert; Sabine Pankuweit
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 2.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

3.  Establishment and assessment of a nomogram model for predicting the risk of fulminant myocarditis: A STROBE compliant cross-sectional study.

Authors:  Guifen Xu; Feizhen Chen; Wenxiang Zhao; Yong Zheng; Wei Zhuang; Fuling Yu
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

Review 4.  Fulminant myocarditis: a comprehensive review from etiology to treatments and outcomes.

Authors:  Weijian Hang; Chen Chen; John M Seubert; Dao Wen Wang
Journal:  Signal Transduct Target Ther       Date:  2020-12-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.